CODX Free Cash Flow Operating Cash Flow Ratio from 2010 to 2024

CODX Stock  USD 0.73  0.00  0.000003%   
Co Diagnostics Free Cash Flow Operating Cash Flow Ratio yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Operating Cash Flow Ratio is likely to outpace its year average in 2024. During the period from 2010 to 2024, Co Diagnostics Free Cash Flow Operating Cash Flow Ratio regression line of annual values had r-squared of  0.02 and arithmetic mean of  1.01. View All Fundamentals
 
Free Cash Flow Operating Cash Flow Ratio  
First Reported
2010-12-31
Previous Quarter
1.06182929
Current Value
1.1
Quarterly Volatility
0.07077056
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Co Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Co Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 18 M, Selling General Administrative of 15 M or Total Revenue of 6.5 M, as well as many indicators such as Price To Sales Ratio of 5.44, Dividend Yield of 0.0 or PTB Ratio of 0.43. CODX financial statements analysis is a perfect complement when working with Co Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Co Diagnostics Correlation against competitors.
For more information on how to buy CODX Stock please use our How to Invest in Co Diagnostics guide.

Latest Co Diagnostics' Free Cash Flow Operating Cash Flow Ratio Growth Pattern

Below is the plot of the Free Cash Flow Operating Cash Flow Ratio of Co Diagnostics over the last few years. It is Co Diagnostics' Free Cash Flow Operating Cash Flow Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Co Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Operating Cash Flow Ratio10 Years Trend
Pretty Stable
   Free Cash Flow Operating Cash Flow Ratio   
       Timeline  

CODX Free Cash Flow Operating Cash Flow Ratio Regression Statistics

Arithmetic Mean1.01
Geometric Mean1.01
Coefficient Of Variation7.02
Mean Deviation0.04
Median1.01
Standard Deviation0.07
Sample Variance0.01
Range0.3173
R-Value(0.13)
Mean Square Error0.01
R-Squared0.02
Significance0.63
Slope(0)
Total Sum of Squares0.07

CODX Free Cash Flow Operating Cash Flow Ratio History

2024 1.1
2023 1.06
2022 0.78
2021 0.98
2020 0.97
2019 1.02

About Co Diagnostics Financial Statements

Co Diagnostics investors use historical fundamental indicators, such as Co Diagnostics' Free Cash Flow Operating Cash Flow Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Co Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Operating Cash Flow Ratio 1.06  1.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CODX Stock Analysis

When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.